944352-62-9

Upstream product

• 111-24-0 1,5-dibromo-pentane 
• 658-99-1 (3,4-difluorophenyl)acetonitrile 
• 944352-59-4 1-(3,4-difluorophenyl)cyclohexanecarbonitrile 

Downstream Products

• 1356464-94-2 (E)-ethyl 3-(1-(3,4-difluorophenyl)cyclohexyl)acrylate 
• 1356464-95-3 ethyl 3-(1-(3,4-difluorophenyl)cyclohexyl)propanoate 
• 1356464-96-4 3-(1-(3,4-difluorophenyl)cyclohexyl)propanoic acid 
• 1356464-97-5 tert-butyl 1-(4-(5-(2-(1-(3,4-difluorophenyl)cyclohexyl)ethyl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate 
• 1356464-98-6 (E)-1-(4-(5-(2-(1-(3,4-difluorophenyl)cyclohexyl)vinyl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic acid 
• 1356464-99-7 (E)-3-(1-(3,4-difluorophenyl)cyclohexyl)acrylic acid 
• 1356465-00-3 (E)-tert-butyl 1-(4-(5-(2-(1-(3,4-difluorophenyl)cyclohexyl)vinyl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylate 

Relevant academic research and scientific papers

SUBSTITUTED 3-PHENYL-1,2,4-OXADIAZOLE COMPOUNDS

Disclosed are compounds of Formula (I): (I) or stereoisomers, salts, or prodrugs thereof, wherein: (i) R1 and R2 are independently C1-C4 alkyl, or (ii) R1 and R2 together with the carbon atom to which they are a

SUBSTITUTED OXADIAZOLE COMPOUNDS AND THEIR USE AS S1P1 AGONISTS

Disclosed are compounds of Formula (I): [PLEASE INSERT CHEMICAL STRUCTURE HERE] or stereoisomers, N-oxides, salts, or prodrugs thereof; wherein: Ring A is phenyl or 5- to 6-membered heteroaryl; (i) R1 and R2 are independently C1-C4 alkyl; or (ii) R1 and R